Related Experiment Video
Updated: Sep 6, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Advances in nanosensors for cardiovascular disease detection
Xiaofang Tang1, Yaping Zhu2, Weijiang Guan2
1Green Catalysis Center, College of Chemistry, Zhengzhou University, Zhengzhou, China.
Abstract:
Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality around the world. The physiological or pathological processes of CVDs can be well indicated by timely and accurate diagnosis of relevant biomarkers and function parameters. Nanosensors integrating the advantages of nanomaterials and sensing platforms have shown good potential for rapid diagnosis of CVDs, especially for early prediction. In this review, recent advances in nanosensors for the detection of CVDs are summarized, including electrochemical, optical, pressure, and paper-based nanosensors. Design strategies for different nanosensors and the corresponding sensing nanomaterials, mechanisms, and properties are briefly discussed. This review also offered a preliminary analysis of the obstacles and prospects for using nanosensors to diagnose CVDs.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

